Elevated gliadin antibody levels in individuals with schizophrenia

References

• Alaedini A, Okamoto H, Briani C, Wollenberg K, Shill HA, Bushara KO, et al. 2007. Immune cross-reactivity in celiac disease: anti-gliadin antibodies bind to neuronal synapsin I. J Immunol 178:6590–6595.
   PubMed Web of Science ®Google Scholar
• Cascella NG, Kryszak D, Bhatti B, Gregory P, Kelly DL, Mc Evoy JP, et al. 2011. Prevalence of Celiac disease and gluten sensitivity in the united states clinical antipsychotic trials of intervention effectiveness study population. Schizophr Bull 37:94–100.
   PubMed Web of Science ®Google Scholar
• Cesca F, Baldelli P, Valtorta F, Benfenati F. 2010. The synapsins: key actors of synapse function and plasticity. Prog Neurobiol 91:313–348.
   PubMed Web of Science ®Google Scholar
• Chong VZ, Young LT, Mishra RK. 2002. cDNA array reveals differential gene expression following chronic neuroleptic administration: implications of synapsin II in haloperidol treatment. J. Neurochem 82:1533–1539.
   Google Scholar
• Dohan FC. 1966. Wheat “consumption” and hospital admissions for schizophrenia during World War II. A preliminary report. Am J Clin Nutr 18:7–10.
   PubMedGoogle Scholar
• Dohan FC, Martin L, Grasberger JC, Boehme D, Cottrell JC. 1972. Antibodies to wheat gliadin in blood of psychiatric patients: possible role of emotional factors. Biol Psychiatry 5:127–137.
   PubMed Web of Science ®Google Scholar
• Dohan FC, Harper EH, Clark MH, Rodrigue RB, Zigas V. 1984. Is schizophrenia rare if grain is rare?. Biol Psychiatry 19:385–399.
   PubMed Web of Science ®Google Scholar
• Dickerson F, Stallings C, Origoni A, Vaughan C, Khushalani S, Leister F, et al. 2010. Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia. Biol Psychiatry 68:100–104.
   PubMed Web of Science ®Google Scholar
• Di Sabatino A, Corazza GR. 2009. Coeliac disease. Lancet 373:1480–1493.
   PubMed Web of Science ®Google Scholar
• Eaton W, Mortensen PB, Agerbo E, Byrne M, Mors O, Ewald H. 2004. Coeliac disease and schizophrenia: population based case control study with linkage of Danish national registers. BMJ 328:438–439.
   PubMed Web of Science ®Google Scholar
• First M, Spitzer R, Gibborn M, et al. 1994. Structured Clinical Interview for DSM-IV Axis II personality disorders (SCID II). New York: Biometric Research Department.
   Google Scholar
• Folstein MF, Robins LN, Helzer JE. 1983. The Mini-Mental State Examination. Arch Gen Psychiatry 40:812.
   PubMed Web of Science ®Google Scholar
• Hart A, Kamm MA. 2002. Review article: mechanisms of initiation and perpetuation of gut inflammation by stress. Aliment Pharmacol Ther 16:2017–2028.
   PubMed Web of Science ®Google Scholar
• Hemmings WA. 1978. The entry into the brain of large molecules derived from dietary protein. Proc R Soc Lond B Biol Sci 200:175–192.
   PubMedGoogle Scholar
• Heyman M. 2005. Gut barrier dysfunction in food allergy. Eur J Gastroenterol Hepatol 17:1279–1285.
   PubMed Web of Science ®Google Scholar
• Hilfiker S, Benfenati F, Doussau F, Nairn AC, Czernik AJ, Augustine GJ. 2005. Structural domains involved in the regulation of transmitter release by synapsins. J Neurosci 25:2658–2669.
   PubMed Web of Science ®Google Scholar
• Jackson JR, Eaton WW, Cascella NG, Fasano A, Kelly DL. 2012. Neurologic and psychiatric manifestations of celiac disease and gluten sensitivity. Psychiatr Q 83:91–102.
   PubMed Web of Science ®Google Scholar
• Jin SZ, Wu N, Xu Q, Zhang X, Ju GZ, Law MH, et al. 2012. A study of circulating gliadin antibodies in schizo phrenia among a Chinese population. Schizophr Bull 38:514–518.
   Google Scholar
• Kalaydjian AE, Eaton W, Cascella N, Fasano A. 2006. The gluten connection: the association between schizophrenia and celiac disease. Acta Psychiatr Scand 113:82–90.
   PubMed Web of Science ®Google Scholar
• Karlsson H, Blomström A, Wicks S, Yang S, Yolken RH, Dalman C. 2012. Maternal antibodies to dietary antigens and risk for nonaffective psychosis in offspring. Am J Psychiatry 10.1176/appi.ajp.2012.11081197.
   Google Scholar
• Kay SR, Fiszbein A, Opler LA. 1987. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 13:261–275.
   PubMed Web of Science ®Google Scholar
• Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B. 2011. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 70:663–671.
   PubMed Web of Science ®Google Scholar
• Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P. 2000. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28:53–67.
   PubMed Web of Science ®Google Scholar
• Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N. 2003. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 161:653–660.
   PubMed Web of Science ®Google Scholar
• Reichelt KL, Landmark J. 1995. Specific IgA antibody increases in schizophrenia. Biol Psychiatry 37:410–413.
   PubMed Web of Science ®Google Scholar
• Rice JP, Reich T, Bucholz KK, Rosalind JN, Fishman R, Rochberg N. 1995. Comparison of direct interview and family history diagnosis of alcohol dependence. Alcohol Clin Exp Res 19:1018–1023.
   PubMed Web of Science ®Google Scholar
• Samaroo D, Dickerson F, Kasarda DD, Green PH, Briani C, Yolken RH, et al. 2010. Novel immune response to gluten in individuals with schizophrenia. Schizophr Res 118:248–255.
   PubMed Web of Science ®Google Scholar
• Singh MM, Kay SR. 1976. Wheat gluten as a pathogenic factor in schizophrenia. Science 191:401–402.
   PubMed Web of Science ®Google Scholar
• Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, et al. 2009. Common variants conferring risk of schizophrenia. Nature 460:744–747.
   PubMed Web of Science ®Google Scholar
• Sun ZY, Wei J, Xie L, Shen Y, Liu SZ, Ju GZ, et al. 2004. The CLDN5 locus may be involved in the vulnerability to schizophrenia. Eur Psychiatry 19:354–357.
   PubMed Web of Science ®Google Scholar
• Vojdani A, O’Bryan T, Green JA, McCandless J, Woeller KN, Vojdani E, et al. 2004. Immune response to dietary proteins, gliadin and cerebellar peptides in children with autism. Nutr Neurosci 7:151–161.
   PubMed Web of Science ®Google Scholar
• Wei J, Hemmings GP. 2005. Gene, gut and schizophrenia: the meeting point for the gene-environment interaction in developing schizophrenia. Med Hypotheses 64:547–552.
   PubMedGoogle Scholar
• Wu N, Zhang X, Jin S, Liu S, Ju G, Wang Z, et al. 2010. A weak association of the CLDN5 locus with schizophrenia in Chinese case-control samples. Psychiatry Res 178:223.
   PubMed Web of Science ®Google Scholar